Yi Yi Yan

Zhejiang Kangle Pharmaceutical Co., Ltd. engages in the research, development, production, sales of pharmaceutical raw materials and preparations. It offers paracetamol powder, erdosteine, hesperidine, silymarin, glucosamine HCl, direct compressible granules, and oral solid preparations. The company was founded in 1945 and is headquartered in Wenzhou, China.

CH-Gemstone Capital Management (Beijing) Co., Ltd. engages in the provision of medical and health care equity investment services. Its business activities include mergers and acquisitions, debt investment and financing, financial consulting, and wealth management financial investment banking services. The company was founded on February 4, 2005 and is headquartered in Beijing, China.

Ch-gemstone Healthcare Holdings (Beijing) Co., Ltd. engages in the provision and development of medical services and IT solutions related to the provision of medical care. Its areas include online treatment systems, integrated healthcare systems, and smart healthcare systems. The company was founded on November 18, 2011 and is headquartered in Beijing, China.

Hunan Tianjicaotang Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese patent medicine. It offers heart-clearing and detoxifying medicine, cardiovascular medicine, and urology medicine. The company was founded on November 20, 1992 and is headquartered in Changsha, China.

Zhejiang Shanxi Water Conservancy & Hydropower Development Co., Ltd. engages in the operation and management of the Shanxi Water Control Project. Its main products are raw water and electricity. The Shanxi Water Control Project is managed and operated by the company, It is composed of the Shanxi River Reservoir Project and the Zhaoshandu Water Diversion Project, provision of overall benefit such as flood control, water supply, irrigation, and power generation. The company was founded on January 15, 1996 and is headquartered in Wenzhou, China.